Moderna Seeks Full Authorization For COVID-19 Vaccine, Will Send Data To FDA
(CBS DETROIT) – Moderna wants full approval from the Food and Drug Administration for its COVID-19 vaccine.
Currently, its vaccine is only authorized for emergency use.
The company says it'll continue to submit trial data to the FDA on a rolling basis over the next few weeks.
Moderna is the second drugmaker to seek full authorization in the United States for a vaccine.
Pfizer applied for it last month.
© 2021 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
